Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP176357E

Novus Biologicals™ IL-34 Antibody Blocking Peptide
SDP

Catalog No. NBP176357E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP176357E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP176357E Supplier Novus Biologicals™ Supplier No. NBP176357PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Western Blot, Antibody Competition

A blocking peptide containing 16 amino acids near the amino terminus of human IL-34. Source: Synthetic (Accession #: ACD13474) The IL-34 Blocking Peptide has been validated for the following applications: Western Blot, Antibody Competition.

Specifications

Gene ID (Entrez) 146433
Species Human
Common Name IL-34
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76357. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias C16orf77, IL-34, interleukin 34
Gene Symbol IL34
Product Type Interleukin 34
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 16 amino acids near the amino terminus of human IL-34
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.